Condition: End Stage Renal Disease · Sponsor: Xeltis
A prospective, single arm, non-randomized feasibility study to confirm the safety and performance of the Xeltis Hemodialysis Access conduit, aXess-E, in subjects older than 18 years with end-stage renal disease, who plan to undergo hemodialysis for at least the first 6 months after study access creation.
This description comes directly from the study's public registry record.
Eliane Schutte · +31 40 751 7614 · clinical@xeltis.com
Always discuss trial participation with your own doctor first.
| Hospital de Santa Maria | Lisbon, Portugal | Recruiting |
| Kliničko bolnički centar Zvezdara Klinika za Interne Bolesti | Belgrade, Serbia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06329310